These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26051503)

  • 1. [Management of chemotherapy-induced anemia in lung cancer].
    Tiotiu A; Clément-Duchêne C; Martinet Y
    Rev Mal Respir; 2015 Oct; 32(8):809-21. PubMed ID: 26051503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced anemia and oncologist perception on treatment: results of a web-based survey.
    Cortinovis D; Beretta G; Piazza E; Luchena G; Aglione S; Bertolini A; Buzzoni R; Cabiddu M; Carnaghi C; Danova M; Farina G; Ferrari V; Frascaroli M; Reni M; Tansini G;
    Tumori; 2013; 99(1):45-50. PubMed ID: 23548999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer.
    Schwartzberg LS; Yee LK; Senecal FM; Charu V; Tomita D; Wallace J; Rossi G
    Oncologist; 2004; 9(6):696-707. PubMed ID: 15561813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frequency of blood transfusions for anemia caused by chemotherapy in ovarian cancer patients. Thoughts about the guidelines modified in 2006 for the treatment of anemic cancer patients by the European Organisation for Research and Treatment of Cancer].
    Lehoczky O; Pulay T
    Orv Hetil; 2007 Nov; 148(45):2133-7. PubMed ID: 17984024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of erythropoiesis stimulating agents].
    Lapierre A; Souquet PJ
    Rev Mal Respir; 2014 Feb; 31(2):162-72. PubMed ID: 24602683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-induced anemia in adults: incidence and treatment.
    Groopman JE; Itri LM
    J Natl Cancer Inst; 1999 Oct; 91(19):1616-34. PubMed ID: 10511589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epoetin beta once weekly: review of its efficacy and safety in patients with chemotherapy-induced anemia.
    Spaëth D
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):875-85. PubMed ID: 18533797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of chemotherapy-induced anemia in lung cancer patients].
    Gálffy G
    Magy Onkol; 2013 Mar; 57(1):39-49. PubMed ID: 23573521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study.
    Aerts JG; Swieboda-Sadlej A; Karanikiotis C; Labourey JL; Galid A; Wheeler T; Pujol B; Van Belle S
    Curr Med Res Opin; 2012 Jul; 28(7):1089-99. PubMed ID: 22642866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of erythropoiesis-stimulating agent use for chemotherapy-induced anemia in lung cancer: results of a retrospective Hungarian real-life clinical data analysis.
    Tamási L; Müller V; Eszes N; Kardos T; Budai M; Vincze K; Losonczy G; Szilasi M
    Expert Opin Drug Saf; 2011 Jul; 10(4):503-7. PubMed ID: 21480764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with beta-erythropoietin in lung cancer--effectiveness and quality of life improvement in clinical practice].
    Tamási L; Gálffy G
    Orv Hetil; 2010 Oct; 151(41):1684-8. PubMed ID: 20880802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options for anemia, taking risks into consideration: erythropoiesis-stimulating agents versus transfusions.
    Spano JP; Khayat D
    Oncologist; 2008; 13 Suppl 3():27-32. PubMed ID: 18458122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of biosimilar epoetin to increase hemoglobin levels in patients with chemotherapy-induced anemia: real-life clinical experience.
    Kerkhofs L; Boschetti G; Lugini A; Stanculeanu DL; Palomo AG
    Future Oncol; 2012 Jun; 8(6):751-6. PubMed ID: 22443466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-related anaemia management in the 21st century.
    Pronzato P
    Cancer Treat Rev; 2006; 32 Suppl 2():S1-3. PubMed ID: 16725269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of cancer chemotherapy-associated anemia in Japan - conditions and issues].
    Yoshino I
    Gan To Kagaku Ryoho; 2014 Apr; 41(4):426-31. PubMed ID: 24743358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents.
    Aapro MS; Link H
    Oncologist; 2008; 13 Suppl 3():33-6. PubMed ID: 18458123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer.
    Thatcher N; De Campos ES; Bell DR; Steward WP; Varghese G; Morant R; Vansteenkiste JF; Rosso R; Ewers SB; Sundal E; Schatzmann E; Stocker H
    Br J Cancer; 1999 May; 80(3-4):396-402. PubMed ID: 10408844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of anemia in cancer patients.
    Calabrich A; Katz A
    Future Oncol; 2011 Apr; 7(4):507-17. PubMed ID: 21463140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses.
    Vansteenkiste J; Glaspy J; Henry D; Ludwig H; Pirker R; Tomita D; Collins H; Crawford J
    Lung Cancer; 2012 Jun; 76(3):478-85. PubMed ID: 22277104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoiesis-stimulating agents in patients with cancer: update on safety issues.
    Pirker R
    Expert Opin Drug Saf; 2009 Sep; 8(5):515-22. PubMed ID: 19637988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.